| Thyroid hormone therapy for older adults with subclinical hypothyroidism DJ Stott, N Rodondi, PM Kearney, I Ford, RGJ Westendorp, SP Mooijaart, ... New England Journal of Medicine 376 (26), 2534-2544, 2017 | 529 | 2017 |
| Fatigue in the Danish general population. Influence of sociodemographic factors and disease T Watt, M Groenvold, JB Bjorner, V Noerholm, NA Rasmussen, P Bech Journal of Epidemiology & Community Health 54 (11), 827-833, 2000 | 296 | 2000 |
| Tests of data quality, scaling assumptions, and reliability of the Danish SF-36 JB Bjorner, MT Damsgaard, T Watt, M Groenvold Journal of clinical epidemiology 51 (11), 1001-1011, 1998 | 294 | 1998 |
| Quality of life in patients with benign thyroid disorders. A review T Watt, M Groenvold, ÅK Rasmussen, SJ Bonnema, L Hegedüs, ... European journal of endocrinology 154 (4), 501-510, 2006 | 287 | 2006 |
| Dansk manual til SF-36 JB Bjørner, MT Damsgaard, T Watt, P Bech, NK Rasmussen, ... København: Lif, 1997 | 244* | 1997 |
| Dimensions of post-stroke fatigue: a two-year follow-up study D Christensen, SP Johnsen, T Watt, I Harder, M Kirkevold, G Andersen Cerebrovascular Diseases 26 (2), 134-141, 2008 | 227 | 2008 |
| Quality of life in the Danish general population–normative data and validity of WHOQOL-BREF using Rasch and item response theory models V Noerholm, M Groenvold, T Watt, JB Bjorner, NA Rasmussen, P Bech Quality of Life Research 13, 531-540, 2004 | 203 | 2004 |
| Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO T Watt, L Hegedüs, M Groenvold, JB Bjorner, ÅK Rasmussen, ... European Journal of Endocrinology 162 (1), 161-167, 2010 | 201 | 2010 |
| Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy KH Winther, P Cramon, T Watt, JB Bjorner, O Ekholm, U Feldt-Rasmussen, ... PloS one 11 (6), e0156925, 2016 | 168 | 2016 |
| Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document J Jonklaas, AC Bianco, AR Cappola, FS Celi, E Fliers, H Heuer, ... European thyroid journal 10 (1), 10-38, 2021 | 165 | 2021 |
| The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects T Watt, P Cramon, L Hegedüs, JB Bjorner, SJ Bonnema, ÅK Rasmussen, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), 3708-3717, 2014 | 149 | 2014 |
| Effect of life history on microRNA expression during C. elegans development X Karp, M Hammell, MC Ow, V Ambros Rna 17 (4), 639-651, 2011 | 140* | 2011 |
| Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association C Marcocci, T Watt, MA Altea, AK Rasmussen, U Feldt-Rasmussen, ... European Journal of Endocrinology 166 (2), 247-253, 2012 | 122 | 2012 |
| Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism SP Mooijaart, RS Du Puy, DJ Stott, PM Kearney, N Rodondi, ... Jama 322 (20), 1977-1986, 2019 | 118 | 2019 |
| Posttraumatic hypopituitarism is associated with an unfavorable body composition and lipid profile, and decreased quality of life 12 months after injury M Klose, T Watt, J Brennum, U Feldt-Rasmussen The Journal of Clinical Endocrinology & Metabolism 92 (10), 3861-3868, 2007 | 115 | 2007 |
| Development of a short version of the thyroid-related patient-reported outcome ThyPRO T Watt, JB Bjorner, M Groenvold, P Cramon, KH Winther, L Hegedüs, ... Thyroid 25 (10), 1069-1079, 2015 | 106 | 2015 |
| Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives T Watt, L Hegedüs, ÅK Rasmussen, M Groenvold, SJ Bonnema, ... Thyroid 17 (7), 647-654, 2007 | 103 | 2007 |
| The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial KH Winther, T Watt, JB Bjørner, P Cramon, U Feldt-Rasmussen, C Gluud, ... Trials 15, 1-11, 2014 | 102 | 2014 |
| Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination T Watt, JB Bjorner, M Groenvold, ÅK Rasmussen, SJ Bonnema, ... Quality of Life Research 18, 483-496, 2009 | 98 | 2009 |
| Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry T Watt, AP Burlina, C Cazzorla, D Schönfeld, M Banikazemi, RJ Hopkin, ... Genetics in Medicine 12 (11), 703-712, 2010 | 89 | 2010 |
